To know appropriate sevoflurane concentration required for laryngeal mask airway placement in childre
Phase 3
Completed
- Conditions
- Health Condition 1: null- Children scheduled for undergoing cataract surgeries
- Registration Number
- CTRI/2015/05/005775
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
•Age 2-8 years
•Either gender
•ASA I and II
•Children scheduled for undergoing cataract surgeries under general anaesthesia with CLMA
Exclusion Criteria
•Airway anomalies.
•Anticipated difficult airway
•Bronchial asthma
•Known cardiac arrhythmia or congenital heart disease.
•Mentally disabled, known case of autism, or developmental pervasive disorder.
•Psychotropic medication use
•Active upper respiratory tract infection
•Patients receiving concurrent treatment with medication known to affect anesthetic requirements.
• Weight of the patient exceeded 150% of the ideal weight.
•The children who will need premedication after randomization will also be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EC50 of Sevoflurane for successful CLMATimepoint: 2.5 minutes and 5.0 minutes after predetermined ET sevoflurane is achieved
- Secondary Outcome Measures
Name Time Method success rate of CLMA placement, attempts to successful placements, incidence of coughing, clenching of teeth, complications Timepoint: At or one minute after LMA <br/ ><br>